ESTABLISHED 2024 A CIVIC RECORD — CONFIRMED ACTIONS, CONFIRMED FACTS May 3, 2026

FDA Names Katherine Szarama as Acting Vaccines Director

The FDA appointed Katherine Szarama as acting director of the Center for Biologics Evaluation and Research, replacing Vinay Prasad. This unit regulates vaccines and biological products for human use. The leadership change may impact vaccine approval processes and biological product oversight.